Publishing research using ab156876? Please let us know so that we can cite the reference in this datasheet.

ab156876 has been referenced in 21 publications.

  • Greenwood HE  et al. Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission Tomography. Clin Cancer Res N/A:N/A (2019). PubMed: 30651275
  • Feng M  et al. LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer. J Exp Clin Cancer Res 37:274 (2018). PubMed: 30419950
  • Zhang J  et al. miR-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells. Cell Physiol Biochem 51:513-527 (2018). PubMed: 30458442
  • Li B  et al. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway. EBioMedicine N/A:N/A (2018). PubMed: 30555042
  • Dong M  et al. Nuclear factor-?B p65 regulates glutaminase 1 expression in human hepatocellular carcinoma. Onco Targets Ther 11:3721-3729 (2018). PubMed: 29988727
  • Daemen A  et al. Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State. Cell Metab 28:383-399.e9 (2018). PubMed: 30043751
  • Lynch DS  et al. GLS loss of function causes autosomal recessive spastic ataxia and optic atrophy. Ann Clin Transl Neurol 5:216-221 (2018). PubMed: 29468182
  • Duan G  et al. Increased Glutamine Consumption in Cisplatin-Resistant Cells Has a Negative Impact on Cell Growth. Sci Rep 8:4067 (2018). PubMed: 29511244
  • Lu Y  et al. Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model. Front Neurosci 12:90 (2018). PubMed: 29515360
  • Ji X  et al. xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. Oncogene N/A:N/A (2018). PubMed: 29789716
  • Liu K  et al. Metabolic Changes Associated with a Rat Model of Diabetic Depression Detected by Ex Vivo 1H Nuclear Magnetic Resonance Spectroscopy in the Prefrontal Cortex, Hippocampus, and Hypothalamus. Neural Plast 2018:6473728 (2018). PubMed: 29849562
  • Krencz I  et al. In situ analysis of mTORC1/2 and cellular metabolism-related proteins in human Lymphangioleiomyomatosis. Hum Pathol N/A:N/A (2018). PubMed: 29885404
  • Lingel H  et al. CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation. Cell Death Differ 24:1739-1749 (2017). PubMed: 28644433
  • Kim B  et al. Glutamine fuels proliferation but not migration of endothelial cells. EMBO J 36:2321-2333 (2017). PubMed: 28659379
  • Velázquez-Villegas LA  et al. PPARa Downregulates Hepatic Glutaminase Expression in Mice Fed Diets with Different Protein:Carbohydrate Ratios. J Nutr 146:1634-40 (2016). PubMed: 27466601
  • Smith MR  et al. Mitochondrial thiol modification by a targeted electrophile inhibits metabolism in breast adenocarcinoma cells by inhibiting enzyme activity and protein levels. Redox Biol 8:136-48 (2016). PubMed: 26774751
  • Matre P  et al. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes. Oncotarget 7:79722-79735 (2016). WB ; Human . PubMed: 27806325
  • Thai M  et al. MYC-induced reprogramming of glutamine catabolism supports optimal virus replication. Nat Commun 6:8873 (2015). WB . PubMed: 26561297
  • Yu D  et al. Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma. Oncotarget 6:7619-31 (2015). IHC ; Human . PubMed: 25844758
  • Xiang Y  et al. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J Clin Invest 125:2293-306 (2015). IHC . PubMed: 25915584
  • Gross MI  et al. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther 13:890-901 (2014). Human . PubMed: 24523301


Sign up